122 related articles for article (PubMed ID: 31785493)
1. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH
J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109
[TBL] [Abstract][Full Text] [Related]
3. Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study.
Sánchez Muñoz-Torrero JF; Escudero-Sánchez G; Calderón-García JF; Rico-Martín S; Robles NR; Bacaicoa MA; Alcalá-Pedrajas JN; Gil-Fernández G; Monreal M; On Behalf Of The Frena Investigators
Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501937
[TBL] [Abstract][Full Text] [Related]
4. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease.
Bernaudo D; Coll R; Sánchez Muñoz-Torrero JF; Pascual MT; García-Díaz AM; Alvarez LR; Monreal M;
Atherosclerosis; 2013 Jul; 229(1):258-62. PubMed ID: 23714334
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
[TBL] [Abstract][Full Text] [Related]
6. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
7. Raised Fibrinogen Levels and Outcome in Outpatients With Peripheral Artery Disease.
Altes P; Perez P; Esteban C; Sánchez Muñoz-Torrero JF; Aguilar E; García-Díaz AM; Álvarez LR; Jiménez PE; Sahuquillo JC; Monreal M;
Angiology; 2018 Jul; 69(6):507-512. PubMed ID: 29113452
[TBL] [Abstract][Full Text] [Related]
8. Concomitant use of proton pump inhibitors and clopidogrel in patients with coronary, cerebrovascular, or peripheral artery disease in the factores de Riesgo y ENfermedad Arterial (FRENA) registry.
Muñoz-Torrero JF; Escudero D; Suárez C; Sanclemente C; Pascual MT; Zamorano J; Trujillo-Santos J; Monreal M;
J Cardiovasc Pharmacol; 2011 Jan; 57(1):13-9. PubMed ID: 21164357
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
[TBL] [Abstract][Full Text] [Related]
10. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol and outcome in outpatients with peripheral artery disease.
Perez P; Esteban C; Sauquillo JC; Yeste M; Manzano L; Mujal A; Jiménez Caballero PE; Aguilar E; Sánchez Muñoz-Torrero JF; Monreal M;
Thromb Res; 2014 Aug; 134(2):331-5. PubMed ID: 24951338
[TBL] [Abstract][Full Text] [Related]
12. Predictors of outcome in stable outpatients with peripheral artery disease.
Sanclemente C; Yeste M; Suarez C; Coll R; Aguilar E; Sahuquillo JC; Lerma R; Monreal M;
Intern Emerg Med; 2014 Feb; 9(1):69-77. PubMed ID: 23054402
[TBL] [Abstract][Full Text] [Related]
13. Concomitant Use of Proton-Pump Inhibitors and Clopidogrel Increases the Risk of Adverse Outcomes in Patients With Ischemic Stroke Carrying Reduced-Function CYP2C19*2.
Yi X; Han Z; Zhou Q; Cheng W; Lin J; Wang C
Clin Appl Thromb Hemost; 2018 Jan; 24(1):55-62. PubMed ID: 27637911
[TBL] [Abstract][Full Text] [Related]
14. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
Inohara T; Pieper K; Wojdyla DM; Patel MR; Jones WS; Tricoci P; Mahaffey KW; James SK; Alexander JH; Lopes RD; Wallentin L; Ohman EM; Roe MT; Vemulapalli S
Am Heart J; 2018 Jul; 201():25-32. PubMed ID: 29910052
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
16. Location of recurrent cardiovascular events and anticardiolipin antibodies.
Galán-González J; Rico-Martín S; Calderón-García JF; Antón J; Ramírez-Moreno JM; Álvarez-Rodríguez LR; Sánchez Muñoz-Torrero JF;
Eur J Clin Invest; 2021 Jul; 51(7):e13533. PubMed ID: 33666941
[TBL] [Abstract][Full Text] [Related]
17. Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.
Pello Lázaro AM; Cristóbal C; Franco-Peláez JA; Tarín N; Aceña Á; Carda R; Huelmos A; Martín-Mariscal ML; Fuentes-Antras J; Martínez-Millá J; Alonso J; Lorenzo Ó; Egido J; López-Bescós L; Tuñón J
PLoS One; 2017; 12(1):e0169826. PubMed ID: 28103324
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
20. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
